The results suggested that ACT001 directly bound to Olig2 protein, induced Olig2 ubiquitination degradation, and inhibit CD133 promoter activity to decrease Olig2 and CD133 protein level in lung cancer. The gene discussed is OLIG2; the disease is lung cancer.